Sumitomo Mitsui Trust Group Inc. Reduces Holdings in National Health Investors, Inc. $NHI

Sumitomo Mitsui Trust Group Inc. reduced its position in shares of National Health Investors, Inc. (NYSE:NHI) by 89.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,558 shares of the real estate investment trust’s stock after selling 420,112 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.11% of National Health Investors worth $4,099,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Metis Global Partners LLC increased its stake in shares of National Health Investors by 34.1% in the second quarter. Metis Global Partners LLC now owns 7,719 shares of the real estate investment trust’s stock worth $541,000 after buying an additional 1,964 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in National Health Investors by 267.4% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,508 shares of the real estate investment trust’s stock valued at $316,000 after acquiring an additional 3,281 shares during the last quarter. Stephens Inc. AR grew its holdings in National Health Investors by 10.8% during the 2nd quarter. Stephens Inc. AR now owns 8,662 shares of the real estate investment trust’s stock worth $607,000 after acquiring an additional 842 shares in the last quarter. Strs Ohio bought a new stake in shares of National Health Investors in the 1st quarter worth about $598,000. Finally, Monument Capital Management bought a new stake in shares of National Health Investors in the 2nd quarter worth about $252,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Price Performance

Shares of NYSE NHI opened at $80.09 on Monday. National Health Investors, Inc. has a 1-year low of $65.22 and a 1-year high of $80.87. The company has a debt-to-equity ratio of 0.74, a current ratio of 10.64 and a quick ratio of 10.64. The business’s fifty day moving average price is $77.80 and its two-hundred day moving average price is $76.04. The firm has a market capitalization of $3.82 billion, a PE ratio of 25.26, a P/E/G ratio of 2.99 and a beta of 0.67.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.08. The company had revenue of $83.36 million during the quarter, compared to the consensus estimate of $85.66 million. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The company’s revenue for the quarter was down 1.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 earnings per share. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, research analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a $0.92 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 annualized dividend and a yield of 4.6%. National Health Investors’s dividend payout ratio is 116.09%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research report on Monday, December 29th. Truist Financial upped their price objective on National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a research note on Monday, December 15th. KeyCorp lifted their target price on National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Cantor Fitzgerald set a $85.00 price target on National Health Investors in a report on Monday, January 5th. Finally, Wells Fargo & Company upped their price target on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, National Health Investors has an average rating of “Buy” and a consensus price target of $86.50.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.